anmelden
OMX Nordic 40
2.733,09
PKT
+2,26
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 16.02.26 | Volvo (B) Buy | UBS AG | |
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 12.02.26 | AstraZeneca Halten | DZ BANK | |
| 12.02.26 | Volvo (B) Buy | UBS AG | |
| 12.02.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 11.02.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 11.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 09.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 09.02.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 06.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 06.02.26 | Novo Nordisk Neutral | UBS AG | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.26 | Novo Nordisk Neutral | UBS AG | |
| 04.02.26 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.02.26 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.02.26 | Nokia Buy | Deutsche Bank AG | |
| 03.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 02.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.02.26 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 02.02.26 | Novo Nordisk Neutral | UBS AG | |
| 02.02.26 | Nokia Buy | Jefferies & Company Inc. | |
| 02.02.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 02.02.26 | Nokia Sell | Goldman Sachs Group Inc. |
